Beyond, results are in accordance with the ability of prucalopride (a 5-HTR4 agonist) combined with donepezil (an acetylcholinesterase inhibitor) to suppress scopolamine-induced amnesia [51]. The gene discussed is ACHE; the disease is amnesia.